Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 2, March

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas

Volume:10   Issue: 2
Pp: 127-134
S. Micuda, D. Rosel, A. Ryska and J. Brabek
DOI: 10.2174/156800910791054202
Published on: 01 March, 2012

Understanding FOXO, New Views on Old Transcription Factors

Volume:10   Issue: 2
Pp: 135-146
F. Zanella, W. Link and A. Carnero
DOI: 10.2174/156800910791054158
Published on: 01 March, 2012

Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A

Volume:10   Issue: 2
Pp: 147-154
A. Izzotti, M. Longobardi, C. Cartiglia, F. D'Agostini, S. Kanitz and S. De Flora
DOI: 10.2174/156800910791054220
Published on: 01 March, 2012

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function open access plus

Volume:10   Issue: 2
Pp: 155-167
A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer
DOI: 10.2174/156800910791054239
Published on: 01 March, 2012

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

Volume:10   Issue: 2
Pp: 168-175
G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero and A. Nencioni
DOI: 10.2174/156800910791054211
Published on: 01 March, 2012

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Volume:10   Issue: 2
Pp: 176-191
R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto
DOI: 10.2174/156800910791054130
Published on: 01 March, 2012

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

Volume:10   Issue: 2
Pp: 192-199
S. Colombo, A. Palmioli, C. Airoldi, R. Tisi, S. Fantinato, S. Olivieri, L. De Gioia, E. Martegani and F. Peri
DOI: 10.2174/156800910791054185
Published on: 01 March, 2012

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

Volume:10   Issue: 2
Pp: 200-209
F. Navid, V. M. Santana and R. C. Barfield
DOI: 10.2174/156800910791054167
Published on: 01 March, 2012

Inhibitors of HDACs - Effective Drugs Against Cancer?

Volume:10   Issue: 2
Pp: 210-228
S. Muller and O. H. Kramer
DOI: 10.2174/156800910791054149
Published on: 01 March, 2012

Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats

Volume:10   Issue: 2
Pp: 229-241
Lunyin Yu, Hari G. Garg, Boyangzi Li, Robert J. Linhardt and Charles A. Hales
DOI: 10.2174/156800910791054176
Published on: 01 March, 2012

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

Volume:10   Issue: 2
Pp: 242-267
M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, H. Pandha, R. Vile and K. Harrington
DOI: 10.2174/156800910791054194
Published on: 01 March, 2012